Could a diabetes pill fight HIV-related obesity?
NCT ID NCT07336797
First seen Jan 18, 2026 · Last updated May 14, 2026 · Updated 20 times
Summary
This study tests whether empagliflozin, a diabetes drug, can help people with HIV who are overweight or obese lose weight and improve their metabolism. About 66 adults with HIV on a specific antiretroviral therapy will receive either the drug or a placebo for 6 months. The main goal is to see if the drug leads to significant weight loss.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (HUMAN IMMUNODEFICIENCY VIRUS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Pharmacy, Cairo University | Kasr El-Aini, Cairo
RECRUITINGCairo, 11562, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.